Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Thanks for your thoughts on thisI cannot find "yet" any more...

First 15144 Last

Share
Profile

Follow
kingkev

27,824 Posts.

1351

30/01/23

18:48

Post #: 65956812
Share

Originally posted by Rickali01: ↑

Hi Kingkev

Reading the articles that have been published about this specific topic over the last few days, IMHO the key part of the discussion relates to 'supplements and food additives' and a reluctance to regulate this part of the market.

At first glance this does appear concerning and whilst it doesn't sound great, I am assuming that the FDA's view on CBD as a supplement could be different from their view on CBD as a medicine, in the same way that Oxycontin is probably not approved by the FDA as something that you can mix with your energy drinks, but is approved by the FDA to treat acute severe pain.

Interestingly, they have kicked it back congress to find a solution, recognising that this is a rapidly growing industry and there is only so long that they can all sit and do nothing.

For the record, I think CBD should be approved as a supplement - in my experience it is an excellent substitute for opiod based medication - it achieves the same outcome but doesn't stuff your system up (again - in my experience).

Given I hold a fair chunk of IHL shares, I hope the above perspective is the right one. Over the next few months I suspect it will become increasingly clear as we look to progress our various programs through the FDA approval process.

Good luck everyone - hoping 2023 is significantly better than the one we just exited.

Expand

Originally posted by thevinnys: ↑

We are lucky to be in the medical space

Dronabinol is a synthetic form of delta-9-tetrahydrocannabinol (THC), which is the main active ingredient in marijuana. Dronabinol is used to treat symptoms of anorexia associated with weight loss in people with AIDS and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. It is marketed under the brand name Syndros and was approved by the FDA in July 2016.

Cannabidiol (CBD)
is a naturally occurring compound found in the cannabis plant. It is a non-psychoactive substance, meaning it does not produce the "high" commonly associated with marijuana use. CBD has been shown to have a range of potential therapeutic benefits, including reducing anxiety, improving sleep, and reducing pain and inflammation.
In 2018, the FDA approved a prescription drug called Epidiolex, which contains pure cannabidiol and is used to treat two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients 2 years of age and older. This approval marked the first time the FDA has approved a drug derived from the cannabis plant. However, it is important to note that the use of marijuana for medicinal purposes remains illegal under federal law.

Good luck all

Expand

Thanks for your thoughts on this

I cannot find "yet" any more info on this but had to share it just in case .........

I actually think we have the science behind us and yes more medical than as a supplement but as always FDA have the last say and trust that Joel, Bob and the crew know so much more about this than me

IHL Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

LML

Lincoln touts its flagship project as key to state government's Green Iron and Steel future

ALY

Alchemy signs farm-in agreement with Japanese government for development of WA's Karonie

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

There are more pages in this discussion • 5,270 more messages in this thread...

First 15144 Last

Add IHL (ASX) to my watchlist